{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:54:20Z","timestamp":1785218060408,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"MHLW Research Program on Rare and Intractable Diseases","award":["JPMH20FC1040"],"award-info":[{"award-number":["JPMH20FC1040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12149-021-01691-8","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T13:02:37Z","timestamp":1636376557000},"page":"200-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Abnormal [18F]fluorodeoxyglucose accumulation to tori tubarius in IgG4-related disease"],"prefix":"10.1007","volume":"36","author":[{"given":"Ken","family":"Nagahata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3468-3586","authenticated-orcid":false,"given":"Masatoshi","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Kamekura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanari","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Yama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisako","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Hatakenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"key":"1691_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.radonc.2020.09.034","volume":"154","author":"MH Valstar","year":"2021","unstructured":"Valstar MH, de Bakker BS, Steenbakkers R, de Jong KH, Smit LA, Klein Nulent TJW, et al. The tubarial salivary glands: A potential new organ at risk for radiotherapy. Radiother Oncol. 2021;154:292\u20138.","journal-title":"Radiother Oncol"},{"key":"1691_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.radonc.2020.12.001","volume":"154","author":"MH Valstar","year":"2021","unstructured":"Valstar MH, de Bakker BS, Steenbakkers R, de Jong KH, Smit LA, Klein Nulent TJW, et al. The tubarial glands paper: A starting point. A reply to comments Radiother Oncol. 2021;154:308\u201311.","journal-title":"A reply to comments Radiother Oncol"},{"key":"1691_CR3","doi-asserted-by":"publisher","unstructured":"Bikker FJ, Vissink A. Letter to the editor concerning Valstar et al. [Radiother Oncol 2020 Sep 23;S0167\u20138140(20)30809\u20134. https:\/\/doi.org\/10.1016\/j.radonc.2020.09.034]. Radiother Oncol. 2021; 154:318.","DOI":"10.1016\/j.radonc.2020.09.034"},{"key":"1691_CR4","doi-asserted-by":"publisher","first-page":"684490","DOI":"10.3389\/fimmu.2021.684490","volume":"12","author":"AA Mentis","year":"2021","unstructured":"Mentis AA, Chrousos GP. Tubarial salivary glands in Sjogren Syndrome: are they just a potential missing link with no broader implications? Front Immunol. 2021;12:684490.","journal-title":"Front Immunol."},{"key":"1691_CR5","volume":"1","author":"Z Wen","year":"2019","unstructured":"Wen Z, John H. Stone. Management of IgG4-related disease. Lancet Rheumatology. 2019;1: e55 65.","journal-title":"Lancet Rheumatology."},{"key":"1691_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3109\/s10165-006-0518-Y","volume":"16","author":"M Yamamoto","year":"2006","unstructured":"Yamamoto M, Takahashi H, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, et al. A new conceptualization for Mikulicz\u2019s disease as an IgG4-related plasmacytic disease. Mod Rheumatol. 2006;16:335\u201340.","journal-title":"Mod Rheumatol"},{"key":"1691_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1056\/NEJM195407012510102","volume":"251","author":"WS Morgan","year":"1954","unstructured":"Morgan WS. The probable systemic nature of Mikulicz\u2019s disease and its relation to Sjogren\u2019s syndrome. N Engl J Med. 1954;251:5\u201310.","journal-title":"N Engl J Med"},{"key":"1691_CR8","doi-asserted-by":"publisher","first-page":"6936727","DOI":"10.1155\/2018\/6936727","volume":"2018","author":"I Puxeddu","year":"2018","unstructured":"Puxeddu I, Capecchi R, Carta F, Tavoni AG, Migliorini P, Puxeddu R. Salivary gland pathology in IgG4-related disease: a comprehensive review. J Immunol Res. 2018;2018:6936727.","journal-title":"J Immunol Res"},{"key":"1691_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13075-015-0698-y","volume":"17","author":"W Li","year":"2015","unstructured":"Li W, Chen Y, Sun ZP, Cai ZG, Li TT, Zhang L, et al. Clinicopathological characteristics of immunoglobulin G4-related sialadenitis. Arthritis Res Ther. 2015;17:186.","journal-title":"Arthritis Res Ther"},{"key":"1691_CR10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3109\/14397595.2014.891964","volume":"24","author":"A Abe","year":"2014","unstructured":"Abe A, Takano K, Seki N, Jitsukawa S, Yamamoto M, Takahashi H, et al. The clinical characteristics of patients with IgG4-related disease with infiltration of the labial salivary gland by IgG4-positive cells. Mod Rheumatol. 2014;24:949\u201352.","journal-title":"Mod Rheumatol"},{"key":"1691_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/acr.22058","volume":"66","author":"M Ebbo","year":"2014","unstructured":"Ebbo M, Grados A, Guedj E, Gobert D, Colavolpe C, Zaidan M, et al. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography\/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res (Hoboken). 2014;66:86\u201396.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1691_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.anl.2016.10.011","volume":"44","author":"K Takano","year":"2017","unstructured":"Takano K, Yamamoto M, Takahashi H, Himi T. Recent advances in knowledge regarding the head and neck manifestations of IgG4-related disease. Auris Nasus Larynx. 2017;44:7\u201317.","journal-title":"Auris Nasus Larynx"},{"key":"1691_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13550-021-00779-6","volume":"11","author":"Y Matsusaka","year":"2021","unstructured":"Matsusaka Y, Yamane T, Fukushima K, Seto A, Matsunari I, Kuji I. Can the function of the tubarial glands be evaluated using [(99m)Tc]pertechnetate SPECT\/CT, [(18)F]FDG PET\/CT, and [(11)C]methionine PET\/CT? EJNMMI Res. 2021;11:34.","journal-title":"EJNMMI Res"},{"key":"1691_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","volume":"79","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, et al. The 2019 American College of Rheumatology\/European league against rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020;79:77\u201387.","journal-title":"Ann Rheum Dis"},{"key":"1691_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13550-020-00743-w","volume":"10","author":"K Mitamura","year":"2020","unstructured":"Mitamura K, Arai-Okuda H, Yamamoto Y, Norikane T, Takami Y, Fujimoto K, et al. Disease activity and response to therapy monitored by [(18)F]FDG PET\/CT using volume-based indices in IgG4-related disease. EJNMMI Res. 2020;10:153.","journal-title":"EJNMMI Res"},{"key":"1691_CR16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3109\/14397595.2014.990674","volume":"25","author":"Y Nakatsuka","year":"2015","unstructured":"Nakatsuka Y, Handa T, Nakamoto Y, Nobashi T, Yoshihuji H, Tanizawa K, et al. Total lesion glycolysis as an IgG4-related disease activity marker. Mod Rheumatol. 2015;25:579\u201384.","journal-title":"Mod Rheumatol"},{"key":"1691_CR17","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1002\/art.34593","volume":"64","author":"JH Stone","year":"2012","unstructured":"Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061\u20137.","journal-title":"Arthritis Rheum"},{"key":"1691_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1148\/radiol.12111349","volume":"263","author":"KS Bhatia","year":"2012","unstructured":"Bhatia KS, King AD, Vlantis AC, Ahuja AT, Tse GM. Nasopharyngeal mucosa and adenoids: appearance at MR imaging. Radiology. 2012;263:437\u201343.","journal-title":"Radiology"},{"key":"1691_CR19","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1148\/radiol.2343030301","volume":"234","author":"Y Nakamoto","year":"2005","unstructured":"Nakamoto Y, Tatsumi M, Hammoud D, Cohade C, Osman MM, Wahl RL. Normal FDG distribution patterns in the head and neck: PET\/CT evaluation. Radiology. 2005;234:879\u201385.","journal-title":"Radiology"},{"key":"1691_CR20","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1007\/s00259-014-2729-3","volume":"41","author":"J Zhang","year":"2014","unstructured":"Zhang J, Chen H, Ma Y, Xiao Y, Niu N, Lin W, et al. Characterizing IgG4-related disease with (1)(8)F-FDG PET\/CT: a prospective cohort study. Eur J Nucl Med Mol Imaging. 2014;41:1624\u201334.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 112","key":"1691_CR21","first-page":"186","volume":"36","author":"T Sasaki","year":"2018","unstructured":"Sasaki T, Akiyama M, Kaneko Y, Yasuoka H, Suzuki K, Yamaoka K, et al. Risk factors of relapse following glucocorticoid tapering in IgG4-related disease. Clin Exp Rheumatol. 2018;36(Suppl 112):186\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"1691_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13075-019-2090-9","volume":"22","author":"J Li","year":"2020","unstructured":"Li J, Peng Y, Zhang Y, Zhang P, Liu Z, Lu H, et al. Identifying clinical subgroups in IgG4-related disease patients using cluster analysis and IgG4-RD composite score. Arthritis Res Ther. 2020;22:7.","journal-title":"Arthritis Res Ther"},{"key":"1691_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/01945998211004256","author":"MJ Wu","year":"2021","unstructured":"Wu MJ, Knoll RM, Chari DA, Remenschneider AK, Faquin WC, Kozin ED, et al. Further research needed to understand relationship between tubarial glands and eustachian tube dysfunction. Otolaryngol Head Neck Surg. 2021. https:\/\/doi.org\/10.1177\/01945998211004256.","journal-title":"Otolaryngol Head Neck Surg."},{"key":"1691_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/198314","author":"S Kawa","year":"2012","unstructured":"Kawa S, Ito T, Watanabe T, Maruyama M, Hamano H, Maruyama M, et al. The utility of serum IgG4 concentrations as a biomarker. Int J Rheumatol. 2012. https:\/\/doi.org\/10.1155\/2012\/198314.","journal-title":"Int J Rheumatol."},{"key":"1691_CR25","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/art.39205","volume":"67","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015;67:2466\u201375.","journal-title":"Arthritis Rheumatol"},{"key":"1691_CR26","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1038\/s41598-018-21996-5","volume":"8","author":"MF Cheng","year":"2018","unstructured":"Cheng MF, Guo YL, Yen RF, Chen YC, Ko CL, Tien YW, et al. Clinical utility of FDG PET\/CT in patients with autoimmune pancreatitis: a case-control study. Sci Rep. 2018;8:3651.","journal-title":"Sci Rep"},{"key":"1691_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/03009742.2015.1055796","volume":"45","author":"C Campochiaro","year":"2016","unstructured":"Campochiaro C, Ramirez GA, Bozzolo EP, Lanzillotta M, Berti A, Baldissera E, et al. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. Scand J Rheumatol. 2016;45:135\u201345.","journal-title":"Scand J Rheumatol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-021-01691-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-021-01691-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-021-01691-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T16:55:13Z","timestamp":1644944113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-021-01691-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1691"],"URL":"https:\/\/doi.org\/10.1007\/s12149-021-01691-8","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"assertion":[{"value":"30 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}